Trxade Group Inc. (MEDS): Price and Financial Metrics
GET POWR RATINGS... FREE!
MEDS POWR Grades
- Momentum is the dimension where MEDS ranks best; there it ranks ahead of 73.95% of US stocks.
- The strongest trend for MEDS is in Growth, which has been heading down over the past 47 weeks.
- MEDS ranks lowest in Growth; there it ranks in the 2nd percentile.
MEDS Stock Summary
- TRxADE HEALTH INC's stock had its IPO on February 13, 2020, making it an older stock than just 2.14% of US equities in our set.
- The price/operating cash flow metric for TRxADE HEALTH INC is higher than 96.11% of stocks in our set with a positive cash flow.
- In terms of twelve month growth in earnings before interest and taxes, TRxADE HEALTH INC is reporting a growth rate of 576%; that's higher than 96.08% of US stocks.
- If you're looking for stocks that are quantitatively similar to TRxADE HEALTH INC, a group of peers worth examining would be HURN, GHSI, BRMK, CIDM, and GHL.
- Visit MEDS's SEC page to see the company's official filings. To visit the company's web site, go to www.trxadegroup.com.
MEDS Valuation Summary
- In comparison to the median Consumer Defensive stock, MEDS's price/sales ratio is 18.52% higher, now standing at 3.2.
- MEDS's EV/EBIT ratio has moved down 465.8 over the prior 19 months.
- MEDS's EV/EBIT ratio has moved down 465.8 over the prior 19 months.
Below are key valuation metrics over time for MEDS.
| Stock | Date | P/S | P/B | P/E | EV/EBIT |
|---|---|---|---|---|---|
| MEDS | 2021-09-03 | 3.2 | 7.4 | -7.9 | -7.2 |
| MEDS | 2021-09-02 | 3.2 | 7.4 | -7.9 | -7.2 |
| MEDS | 2021-09-01 | 3.2 | 7.2 | -7.8 | -7.1 |
| MEDS | 2021-08-31 | 3.3 | 7.6 | -8.1 | -7.4 |
| MEDS | 2021-08-30 | 3.1 | 7.1 | -7.6 | -6.9 |
| MEDS | 2021-08-27 | 3.1 | 7.2 | -7.7 | -7.0 |
MEDS's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- MEDS has a Quality Grade of C, ranking ahead of 32.78% of graded US stocks.
- MEDS's asset turnover comes in at 1.389 -- ranking 56th of 104 Wholesale stocks.
- AMRK, CAH, and CENT are the stocks whose asset turnover ratios are most correlated with MEDS.
The table below shows MEDS's key quality metrics over time.
| Period | Asset Turnover | Gross Margin | ROIC |
|---|---|---|---|
| 2021-06-30 | 1.389 | 0.323 | -1.537 |
| 2021-03-31 | 1.669 | 0.303 | -0.703 |
| 2020-12-31 | 1.527 | 0.333 | -0.550 |
| 2020-09-30 | 1.656 | 0.406 | -0.162 |
| 2020-06-30 | 1.479 | 0.485 | -0.215 |
| 2020-03-31 | 1.223 | 0.660 | -0.071 |
MEDS Price Target
For more insight on analysts targets of MEDS, see our MEDS price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
| Average Price Target | $8.67 | Average Broker Recommendation | 1.33 (Strong Buy) |
MEDS Stock Price Chart Interactive Chart >
MEDS Price/Volume Stats
| Current price | $5.12 | 52-week high | $10.82 |
| Prev. close | $5.06 | 52-week low | $3.10 |
| Day low | $5.02 | Volume | 39,400 |
| Day high | $5.18 | Avg. volume | 2,084,539 |
| 50-day MA | $5.10 | Dividend yield | N/A |
| 200-day MA | $5.26 | Market Cap | 41.78M |
Trxade Group Inc. (MEDS) Company Bio
Trxade Group, Inc. provides an on-line platform for pharmaceutical purchasers. It owns and operates a business-to-business web-based marketplace focuses on the United States pharmaceutical industry. It operates web-based market platform that enables trade among healthcare buyers and sellers of pharmaceuticals, accessories and services; provides state-licensed pharmacies and buying groups in the United States with pharmaceuticals approved by the United States Food and Drug Administration; and acts as technology consultant provider that supports their programming needs and provides research on pharmaceutical pricing and shortages in acute care and retail settings. The company was founded on July 15, 2005 and is headquartered in Land O' Lakes, FL.
Latest MEDS News From Around the Web
Below are the latest news stories about TRxADE HEALTH INC that investors may wish to consider to help them evaluate MEDS as an investment opportunity.
TRxADE HEALTH to Present at Upcoming Investor Conferences in SeptemberTAMPA, FL / ACCESSWIRE / September 7, 2021 / TRxADE HEALTH, INC. (NASDAQ:MEDS), a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U. |
Bonum Health, a TRxADE Company, Launches Pre-Paid Digital Telemedicine PasseseGift Cards Enable Pre-Paid Telemedicine Visits, an Innovative New Way for Uninsured Consumers to Gain Access to Vital Healthcare ServicesPre-Paid Digital Passes Provide Streamlined Path for Organizations to Gift Healthcare to Those in NeedTAMPA, FL/ ACCESSWIRE / August 10, 2021 / TRxADE HEALTH, INC. (NASDAQ:MEDS), an integrated drug procurement, delivery, and healthcare platform, today announced that its telehealth subsidiary, Bonum Health, has launched an eGift Card program as an innovative ne |
TRxADE HEALTH, Inc. (NASDAQ:MEDS) Analysts Just Slashed This Year's EstimatesThe analysts covering TRxADE HEALTH, Inc. ( NASDAQ:MEDS ) delivered a dose of negativity to shareholders today, by... |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on TuesdayGreetings, trader! |
TRxADE HEALTH Reports Second Quarter 2021 Financial ResultsQ2 2021 Gross Profit Margin Expands Significantly to 44.3%TAMPA, FL / ACCESSWIRE / July 26, 2021 / TRxADE HEALTH, INC. |
MEDS Price Returns
| 1-mo | 9.87% |
| 3-mo | 13.78% |
| 6-mo | -23.58% |
| 1-year | 1.39% |
| 3-year | N/A |
| 5-year | 50.87% |
| YTD | -3.21% |
| 2020 | -19.85% |
| 2019 | N/A |
| 2018 | 0.00% |
| 2017 | N/A |
| 2016 | 0.00% |
Loading social stream, please wait...